Mortality of human epidermal keratinocytes in co-culture with oral squamous cell carcinoma cells

Anticancer Research

Volumn 23, Issue 1 A, 2003, Pages 79-84

  Sawaki, Koichi ^a   Yamaai, Tomoichiro ^a   Mizukawa, Nobuyoshi ^a   Yoshimoto, Tomohitio ^a   Ueno, Takaaki ^a   Nakano, Makoto ^a   Sugahara, Toshio ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

defensin 2 (HBD 2); Labeling index (LI); Mitotic index (MI); Normal human epidermal keratinocyte (NHEK); Squamous cell carcinoma

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 2; BROXURIDINE; DRUG ANTIBODY; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELL SHAPE; CELL STRUCTURE; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DNA SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; LABELING INDEX; MITOSIS INDEX; MITOSIS RATE; MOUTH CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

BETA-DEFENSINS; BROMODEOXYURIDINE; CARCINOMA, SQUAMOUS CELL; CELL COMMUNICATION; CELL DEATH; CELL DIVISION; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; EPIDERMIS; HUMANS; KERATINOCYTES; MITOSIS; MOUTH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0345700307     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Hoffmann JA and Hetru C: Insect defensins: inducible antibacterial peptides. Immunol Today 13: 411-415, 1992.
2. Cociancich S, Ghazi A, Hetru C, Hoffmann JA and Letellieeer L: Insect defensins, an inducible antibacterial peptide, forms voltage-dependent channels in Micrococcus luteus. J Biol Chem 268: 19239-19245, 1993.
3. Barnathan ES, Raghunath PN, Tomaszewski JE, Ganz T, Cines DB and Higazi AAR: Immunohistochemical localization of defensin in human coronary vessels. Am J Pathol 150: 1009-1020, 1997.
4. Schroder JM and Harder J: Molecules in focus Human beta-defensin-2. Int J Biochem & Cell Biol 31: 645-651, 1999.
5. Dutis LA, Rademaker M, Ravensbergen B, van Sterkenburg MAJA, van Strijen E, Hiemstra PS and Nibbering PH: Inhibition of hBD-3, but not hBD-1 and hBD-2, mRNA expression by corticosteroids. Biochem Biophys Res Commun 280: 522-525, 2001.
6. Sawaki K, Mizukawa N, Yamaai T, Fukunaga J and Sugahara T: Immunohistochemical study on expression of alpha-defensin and beta-defensin-2 in human buccal epithelia with candidiasis. Oral Dis 8(1): 37-41, 2002.
7. Bensch KW, Raida M, Magert HJ, Schulz-Knappe P and Forssmann WG: hBD-1: A novel β-defensin from human plasma. FEBS Letters 368: 331-335, 1995.
8. Ganz T and Lehrer RI: Defensins. Pharmacol Ther 66: 191-205, 1995.
9. Harder J, Bartels J, Christophers E and Schroder JM: Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276: 5707-5713, 2001.
10. Jones DE and Bevins CL: Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 267: 23216-23225, 1992.
11. Schonwetter BS, Stolzenberg ED and Zasloff MA: Epithelial antibiotics induced at sites of inflammation. Science 267: 1645-1648, 1995.
12. Harder J, Bartels J, Christophers E and Schroder JM: A peptide antibiotic from human Skin. Nature 387: 861, 1997.
13. Huttner KM, Brezinski DJC, Mahoney MM and Diamond G: Antimicrobial peptide expression is developmentally regulated in ovine gastrointestinal tract. J Nutr 128: 297S-299S, 1998.
14. Mathews M, Jia HP, Guthmiller JM, Losh G, Graham S, Johnson GK, Tack BF and McCray PB Jr.: Production of β-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun 67: 2740-2745, 1999.
15. Tarver AP, Clark DP, Diamond G, Russel JP, Erdjument-Bromage H, Tempst T, Cohen KS, Jones DE, Sweeney RW, Wines M, Hwangs S and Bevins CL: Enteric β-defensin:molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection. Infect Immun 66: 1045-1056, 1998.
16. Garcia JRC, Krause A, Schulz S, Rodriguez-Jimenez FJ, Kluver E, Adermann K, Forssmann U, Frimpong-Boateng A, Bals R and Forssmann WJ: Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 15: 1819-1821, 2001.
17. Dunsche A, Acil Y, Dommisch H, Siebert R, Schroder JM and Jepsen S: The novel human beta-defensin-3 is widely expressed in oral tissues. Eur J Oral Sci 110(2): 121-124, 2002.
18. Weinberg A, Krisanaprakornkit S and Dale BA: Epithelial antimicrobial peptides: review and significance for oral applications. Crit Rev Oral Biol Med 9: 399-314, 1998.
19. Krisanaprakornkit S, Kimball JR, Weinberg A, Darveau RP, Bainbridge BW and Dale BA: Inducible expression of human β-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: Multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier, Infect Immun 68: 2907-2915, 2000.
20. Schroder JM: Epithelial peptide antibiotics. Biochem Pharmacol 57: 121-134, 1999.
21. Mizukawa N, Sugiyama K, Fukunaga J, Ueno T, Mishima K, Takagi S and Sugahara T: Defensin-1, a peptide detected in saliva of oral squamous cell carcinoma patients. Anticancer Res 18: 4645-4650, 1998.
22. Mizukawa N, Sugiyama K, Ueno T, Mishima K, Takagi S and Sugahara T: Defensin-1, an antimicrobial peptide present in saliva with oral diseases. Oral Diseases 5: 139-142, 1999.
23. Mizukawa N, Sawaki K, Yamachika E, Fukunaga J, Ueno T, Takagi S and Sugahara T: Presence of human β-defensin-2 in oral squamous cell carcinoma. Anticancer Res 20: 2005-2008, 2000.
24. Mizukawa N, Sawaki K, Nagatsuka H, Kamio M, Yamachika E, Fukunaga J, Ueno T, Takagi S and Sugahara T: Human α and β-defensin immunoreactivity in oral mucoepidermoid carcinomas. Anticancer Res 21: 2171-2174, 2001.
25. Abiko Y, Suraweera AK, Nishimura M, Muramatsu T, Inoue T, Shimono M and Kaku T: Differential expression of human β-defensin 2 in keratinized and non-keratinized oral epithelial lesions;immunohistochemistry and in situ hybridization. Virchows Arch 438: 248-253, 2001.
26. Mizukawa N, Sugiyama K, Kamio M, Yamachika E, Ueno T, Fukunaga J, Takagi S and Sugahara T: Immunohistochemical staining of human α-defensin-1 (HNP-1), in the submandibular glands of patients with oral carcinomas, Anticancer Res 20: 1125-1128, 2000.
27. Mizukawa N, Sugiyama K, Yamachika E, Ueno T, Mishima K, Takagi S and Sugahara T: Presence of defensin in epithelial Langerhans cells adjacent to oral carcinomas and precancerous lesions. Anticancer Res 19: 2969-2972, 1999.
28. Becker MN, Diamond G, Verghese MW and Randell SH: CD-14-dependent LPS-induced β-defensin-2 expressed in human tracheobronchea epithelium. J Biol Chem 275: 29731-2973, 2000.
29. Liu AY, Destoumieux D, Wong AV, Park CH, Valore EV, Liu L and Ganz T: Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol 118(2): 275-281, 2002.
30. Birchler T, Seibl R, Buchner K, Loeliger S, Seger R, Hossle JP, Aguzzi A and Lauener RP: Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein. Eur J Immunol 31(11): 3131-3137, 2001.
31. Tsutsumi-Ishii Y and Nagaoka I: NF-kappa B-mediated transcriptional regulation of human beta-defensin-2 gene following lipopolysaccharide stimulation. J Leukoc Biol 71(1): 154-162, 2002.
32. Abiko Y, Mitamura J, Nishimura M, Muramatsu T, Inoue T, Shimono M and Kaku T: Pattern of expression of beta-defensins in oral squamous cell carcinoma. Cancer Lett 143: 37-43, 1999.
33. Coggle JE: Biological Effects of Radiation. pp35-44, London: Wykeham Publications, 1971.